Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer
Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.